This study assesses linear grown in preschool children treated with mass azithromycin distributions for trachoma.
This study suggests biannual administration of single-dose azithromycin to children does not result in excess azithromycin resistance in S. pneumoniae and E. coli isolates over 24 months of follow-up.
This study modeled the cost-effectiveness of MDA to children 1-59 months of age, MDA to children 1-5 months of age, AZM administered at hospital discharge, and the combination of MDA and post-discharge AZM.
This cross-sectional survey of households of children with active trachoma sought to determine if the presence of Chlamydia trachomatis could be detected on household objects and on family members based on sleeping and caretaking patterns.
The aim of this study was to determine the prevalence and associated factors of active trachoma among children in Ethiopia.
This protocol presents the methods of two randomized controlled trials designed to evaluate mass and targeted azithromycin distribution for the prevention of child mortality in Burkina Faso, West Africa.
The objective of this study was determining the prevalence of active trachoma and associated factors among children aged 1 to 9 years in rural community of Lemo district.
This study suggests that the effect of infection on scarring progression is mediated through papillary inflammation, and that other factors contributing to the development of inflammation, in addition to C. trachomatis infection, may be important in driving conjunctival scarring progression in children.